Global Cord Blood (CO) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Global Cord Blood Corp  (NYSE: CO)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Select the Financial Report: Select the Period:


Description of Global Cord Blood's Business Segments


Global Cord Blood Corporation (GCBC) is a prominent player in the field of cord blood banking, with a strong focus on the collection, processing, and storage of umbilical cord blood stem cells. The company operates primarily in two key segments: China and Hong Kong, where it offers a range of services designed to meet the needs of families and the broader medical community.

Segments

1. China:
- Presence and Market Leadership: GCBC has established a significant footprint in China, with its main operational hub located in Beijing. This position allows GCBC to cater to a large population that increasingly recognizes the importance of cord blood banking for future medical applications.
- Cord Blood Services: The company provides comprehensive cord blood collection, processing, and storage services for families wishing to preserve their newborns’ cord blood for potential future therapies.
- Public Cord Blood Bank: GCBC is also a pioneer in operating a public cord blood bank in China. This bank serves as a vital resource for those in need of stem cell transplants, facilitating the treatment of various conditions such as leukemia, thalassemia, and certain genetic disorders. The public bank not only helps generate a donor pool but also enhances accessibility for patients requiring these critical therapies.

2. Hong Kong:
- Operational Distinctiveness: In Hong Kong, GCBC operates as a separate entity with its own management team, reflecting the regulatory and market characteristics of the region.
- Umbilical Cord Blood Banking: Like its operations in China, GCBC offers similar services in Hong Kong, assuring families of high-quality collection, processing, and storage of cord blood. The services are tailored to meet local healthcare standards and family needs.

Products and Services

1. Cord Blood Collection:
- Professional Collection Services: GCBC provides dedicated services for the collection of cord blood at the time of birth. With trained medical personnel mobilized to hospitals or specific birthing locations, the company ensures a sterile and efficient collection process. Cord blood is collected using safe and standardized protocols to maximize the viability of stem cells.

2. Cord Blood Processing:
- State-of-the-Art Technology: Post-collection, cord blood undergoes rigorous processing using cutting-edge technology. The collected cells are meticulously tested to meet stringent quality standards before being prepared for storage. This phase often includes the isolation of stem cells and analysis to ensure their viability and functionality.

3. Cord Blood Storage:
- Cryopreservation Facilities: GCBC operates advanced facilities equipped with modern cryopreservation technology. The processed stem cells are stored in conducive conditions within sterile, single-use bags. The tanks used for storage are regularly monitored to maintain optimal temperatures and environmental conditions, ensuring the longevity of the stem cells.

4. Dual Storage:
- Enhanced Security Measures: To further safeguard the preserved stem cells, GCBC offers a dual storage option. This involves storing the samples in two distinct locations, which significantly reduces the risk of loss due to unforeseen circumstances, thus providing families with additional peace of mind.

5. Public Cord Blood Banking:
- Community Impact: The public cord blood bank managed by GCBC plays a crucial role in promoting community health. Parents who opt for donation can contribute to a public inventory that serves patients needing stem cell transplants across various medical conditions. This initiative supports the principle of altruism in healthcare while expanding access for those in critical need.

6. Genetic Testing and HLA Matching:
- Supporting Personalized Medicine: GCBC offers genetic testing services that can help families understand potential hereditary conditions. Additionally, HLA (Human Leukocyte Antigen) matching services ensure that stem cell donors and recipients are properly matched, improving the likelihood of successful transplants and treatment outcomes. These services are particularly valuable in the context of personalized medicine approaches.

Consultative Services:
- Family Support and Education: GCBC engages with families to educate them about the benefits of cord blood banking, the procedures involved, and potential medical applications. The organization provides consultative support to help prospective clients make informed decisions regarding their cord blood storage options.

In conclusion, Global Cord Blood Corporation offers a holistic suite of services focused on the preservation and utilization of umbilical cord blood stem cells. The companys operational strength in China and Hong Kong, combined with its commitment to quality and community support through public banking efforts, positions GCBC as a leader in the field. Its advanced technologies, strong focus on safety and security, as well as complementary services like genetic testing, underline its comprehensive approach to cord blood banking and stem cell preservation.




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.